Evidence map›Paper›PMID 38138044›Full record

ArticleMicroorganisms2023

Modulation of Zebrafish (

Mark Rawling, Marion Schiavone, Amélie Mugnier, Eric Leclercq, Daniel Merrifield, Andrew Foey, Emmanuelle Apper

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Postbiotic potential of heat-inactivated Limosilactobacillus reuteri and its cell-free supernatant in protecting intestinal health of zebrafish.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Animals : an open access journal from MDPI · 2025
    Article
  9. Article
  10. Immunomodulatory effects of probioticFrontiers in microbiology · 2025
    Article
  11. Brewers' Yeast (Aquaculture nutrition · 2025
    Article
  12. Immunomodulatory effects ofFrontiers in immunology · 2025
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mark RawlingAquatic Animal Nutrition and Health Research Group, School of Marine and Biological Sciences, Plymouth University, Plymouth, Devon PL4 8AA, UK.
Marion SchiavoneLallemand SAS, 19 rue des Briquetiers, 31702 Blagnac, France.ORCID 0000-0002-8231-2053
Amélie MugnierLallemand SAS, 19 rue des Briquetiers, 31702 Blagnac, France.ORCID 0000-0001-9711-1679
Eric LeclercqLallemand SAS, 19 rue des Briquetiers, 31702 Blagnac, France.
Daniel MerrifieldAquatic Animal Nutrition and Health Research Group, School of Marine and Biological Sciences, Plymouth University, Plymouth, Devon PL4 8AA, UK.ORCID 0000-0002-1790-2217
Andrew FoeyAquatic Animal Nutrition and Health Research Group, School of Marine and Biological Sciences, Plymouth University, Plymouth, Devon PL4 8AA, UK.ORCID 0000-0003-0419-2268
Emmanuelle ApperLallemand SAS, 19 rue des Briquetiers, 31702 Blagnac, France.ORCID 0000-0002-8986-2082
Lallemand (France) · FRUniversity of Plymouth · GB

Funding

Lallemand (Canada) private funding
6 · The paper itself

Abstract

It is generally accepted that microbes play a critical role in maintaining gut barrier function, making them ideal to target in order to mitigate the effects of intestinal diseases such as inflammatory bowel disease with specialist supplementations such as probiotic or postbiotic preparations. In this study, specific strains of

Indexed as

intestinal barrier functionlactobacillipostbioticsprobioticszebrafish

Identifiers

PMID38138044
PMCPMC10745996
OpenAlexW4389237669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.